Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells

被引:43
作者
Ikeda, U
Kurosaki, K
Ohya, K
Shimada, K
机构
[1] Department of Cardiology, Jichi Medical School, Tochigi 329-04, Minamikawachi-Machi
关键词
rat; adenosine; interleukin-1; nitric oxide; cAMP; vascular smooth muscle cell;
D O I
10.1016/S0008-6363(97)00068-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim was to investigate the effects of adenosine on nitric oxide (NO) synthesis in vascular smooth muscle cells. Methods: NO and cAMP synthesis was measured in confluent rat vascular smooth muscle cells in culture at passage 5-10, using Griess reagent and an enzyme immunoassay kit, respectively. The expression of inducible NO synthase mRNA was assayed by Northern blotting. Results: Incubation of cultures with interleukin-1 beta (10 ng/ml) for 24 h caused a significant increase in nitrite production. The interleukin-1 beta-induced nitrite production by vascular smooth muscle cells was significantly increased by adenosine or its stable analogue, 2-chloroadenosine, in a dose-dependent manner. The adenosine A(2a) receptor antagonist, KF17837, but not the A(1) receptor antagonist; DPCPX, significantly inhibited 2-chloroadenosine-mediated nitrite production. The 2-chloroadenosine-induced nitrite production by interleukin-1 beta-stimulated cells was accompanied by increased inducible NO synthase mRNA accumulation. In the presence of dibutyryl-cAMP(1 mM), interleukin-1 beta-induced nitrite accumulation was further increased, but the effect of 2-chloroadenosine was not additive or synergistic. Addition of 2-chloroadenosine dose-dependently increased intracellular cAMP levels of vascular smooth muscle cells. Conclusions: These results indicate that adenosine acts on A(2) receptors and augments NO synthesis in interleukin-1 beta-stimulated vascular smooth muscle cells, at least partially through a cAMP-dependent pathway.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 42 条
[1]   PRESENCE OF RA AND P-SITE RECEPTORS FOR ADENOSINE COUPLED TO ADENYLATE-CYCLASE IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
ANANDSRIVASTAVA, MB ;
FRANKS, DJ ;
CANTIN, M ;
GENEST, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (01) :213-219
[2]  
BOBIK A, 1993, PHARMACOL REV, V45, P1
[3]  
Buttery LDK, 1996, LAB INVEST, V75, P77
[4]   INHIBITION OF PLATELET-AGGREGATION BY ADENOSINE RECEPTOR AGONISTS [J].
CRISTALLI, G ;
VITTORI, S ;
THOMPSON, RD ;
PADGETT, WL ;
SHI, D ;
DALY, JW ;
OLSSON, RA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 349 (06) :644-650
[5]   ADENOSINE, AN ENDOGENOUS ANTIINFLAMMATORY AGENT [J].
CRONSTEIN, BN .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 76 (01) :5-13
[6]  
DALZIEL HH, 1994, PHARMACOL REV, V46, P449
[7]   MOLECULAR MECHANISMS OF NITRIC-OXIDE REGULATION - POTENTIAL RELEVANCE TO CARDIOVASCULAR-DISEASE [J].
DINERMAN, JL ;
LOWENSTEIN, CJ ;
SNYDER, SH .
CIRCULATION RESEARCH, 1993, 73 (02) :217-222
[8]   Adenosine inhibits growth of rat aortic smooth muscle cells - Possible role of A(2b) receptor [J].
Dubey, RK ;
Gillespie, DG ;
Osaka, K ;
Suzuki, F ;
Jackson, EK .
HYPERTENSION, 1996, 27 (03) :786-793
[9]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
[10]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF N-6-BENZYLADENOSINE-5'-URONAMIDES AS A(3)-SELECTIVE ADENOSINE AGONISTS [J].
GALLORODRIGUEZ, C ;
JI, XD ;
MELMAN, N ;
SIEGMAN, BD ;
SANDERS, LH ;
ORLINA, J ;
FISCHER, B ;
PU, QL ;
OLAH, ME ;
VANGALEN, PJM ;
STILES, GL ;
JACOBSON, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :636-646